New investigations into retatrutide, a dual agonist for GLP-1 and GIP receptors, are showing promising results in managing weight gain and type 2 disease. Preclinical evidence suggest a novel process contributing to https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/